JP2018012712A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2018012712A5 JP2018012712A5 JP2017160217A JP2017160217A JP2018012712A5 JP 2018012712 A5 JP2018012712 A5 JP 2018012712A5 JP 2017160217 A JP2017160217 A JP 2017160217A JP 2017160217 A JP2017160217 A JP 2017160217A JP 2018012712 A5 JP2018012712 A5 JP 2018012712A5
- Authority
- JP
- Japan
- Prior art keywords
- amino
- methyl
- ethyl
- dimethylamino
- methoxyphenyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201462014500P | 2014-06-19 | 2014-06-19 | |
| US62/014,500 | 2014-06-19 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016573910A Division JP6230205B2 (ja) | 2014-06-19 | 2015-05-13 | キナーゼ阻害のためのヘテロアリール化合物 |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019115443A Division JP2019194217A (ja) | 2014-06-19 | 2019-06-21 | キナーゼ阻害のためのヘテロアリール化合物 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2018012712A JP2018012712A (ja) | 2018-01-25 |
| JP2018012712A5 true JP2018012712A5 (https=) | 2018-06-21 |
| JP6546630B2 JP6546630B2 (ja) | 2019-07-17 |
Family
ID=54935960
Family Applications (5)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016573910A Active JP6230205B2 (ja) | 2014-06-19 | 2015-05-13 | キナーゼ阻害のためのヘテロアリール化合物 |
| JP2017160217A Active JP6546630B2 (ja) | 2014-06-19 | 2017-08-23 | キナーゼ阻害のためのヘテロアリール化合物 |
| JP2019115443A Withdrawn JP2019194217A (ja) | 2014-06-19 | 2019-06-21 | キナーゼ阻害のためのヘテロアリール化合物 |
| JP2021131767A Active JP7212733B2 (ja) | 2014-06-19 | 2021-08-12 | キナーゼ阻害のためのヘテロアリール化合物 |
| JP2023003712A Pending JP2023052388A (ja) | 2014-06-19 | 2023-01-13 | キナーゼ阻害のためのヘテロアリール化合物 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016573910A Active JP6230205B2 (ja) | 2014-06-19 | 2015-05-13 | キナーゼ阻害のためのヘテロアリール化合物 |
Family Applications After (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019115443A Withdrawn JP2019194217A (ja) | 2014-06-19 | 2019-06-21 | キナーゼ阻害のためのヘテロアリール化合物 |
| JP2021131767A Active JP7212733B2 (ja) | 2014-06-19 | 2021-08-12 | キナーゼ阻害のためのヘテロアリール化合物 |
| JP2023003712A Pending JP2023052388A (ja) | 2014-06-19 | 2023-01-13 | キナーゼ阻害のためのヘテロアリール化合物 |
Country Status (42)
Families Citing this family (96)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2704572B1 (en) | 2011-05-04 | 2015-12-30 | Ariad Pharmaceuticals, Inc. | Compounds for inhibiting cell proliferation in egfr-driven cancers |
| WO2013169401A1 (en) | 2012-05-05 | 2013-11-14 | Ariad Pharmaceuticals, Inc. | Compounds for inhibiting cell proliferation in egfr-driven cancers |
| US9611283B1 (en) | 2013-04-10 | 2017-04-04 | Ariad Pharmaceuticals, Inc. | Methods for inhibiting cell proliferation in ALK-driven cancers |
| EP3778584A1 (en) * | 2014-06-19 | 2021-02-17 | ARIAD Pharmaceuticals, Inc. | Production process of 2-chloro-4-heteroaryl-pyrimidine derivatives |
| CN106458969A (zh) * | 2014-08-25 | 2017-02-22 | 四川海思科制药有限公司 | 一种(取代的苯基)(取代的嘧啶)胺基衍生物及其制备方法和药物用途 |
| WO2016054987A1 (zh) * | 2014-10-11 | 2016-04-14 | 上海翰森生物医药科技有限公司 | Egfr抑制剂及其制备和应用 |
| HUE054848T2 (hu) | 2014-10-13 | 2021-09-28 | Yuhan Corp | Vegyületek és készítmények EGFR mutáns kináz aktivitás módosítására |
| CN105085489B (zh) | 2014-11-05 | 2019-03-01 | 益方生物科技（上海）有限公司 | 嘧啶或吡啶类化合物、其制备方法和医药用途 |
| JP6709786B2 (ja) | 2014-12-11 | 2020-06-17 | ベータ ファーマ，インコーポレイテッド | Ｅｇｆｒモジュレーターとしての置換２−アミノピリミジン誘導体 |
| EP3294712A4 (en) * | 2015-05-13 | 2018-11-07 | ARIAD Pharmaceuticals, Inc. | Heteroaryl compounds for kinase inhibition |
| WO2017035753A1 (zh) * | 2015-08-31 | 2017-03-09 | 无锡双良生物科技有限公司 | 2-芳胺基吡啶、嘧啶或三嗪衍生物及其制备方法和用途 |
| CN106117185B (zh) * | 2015-08-31 | 2017-11-07 | 广州必贝特医药技术有限公司 | 2,4‑二含氮基团取代嘧啶类化合物及其制备方法和应用 |
| SG11201805286RA (en) * | 2015-12-24 | 2018-07-30 | Kyowa Hakko Kirin Co Ltd | α,β-UNSATURATED AMIDE COMPOUND |
| TWI726968B (zh) * | 2016-01-07 | 2021-05-11 | 開曼群島商Ｃｓ醫藥技術公司 | Egfr酪胺酸激酶之臨床重要突變體之選擇性抑制劑 |
| WO2017119732A1 (en) | 2016-01-08 | 2017-07-13 | Samsung Electronics Co., Ltd. | Electronic device and operating method thereof |
| CN108610331A (zh) * | 2016-01-22 | 2018-10-02 | 焦玉奇 | 2-(2,4,5-取代苯胺)嘧啶衍生物 |
| TWI745345B (zh) * | 2016-02-01 | 2021-11-11 | 瑞典商阿斯特捷利康公司 | 製備奧希替尼（osimertinib，azd9291）或其鹽及「azd9291苯胺」或其鹽的改良方法 |
| US11753626B2 (en) | 2016-03-09 | 2023-09-12 | Beijing Percans Oncology Co., Ltd. | Tumor cell suspension cultures and related methods |
| CN112645932B (zh) * | 2016-03-22 | 2022-01-14 | 江苏豪森药业集团有限公司 | Egfr抑制剂游离碱或其酸式盐的多晶型、其制备方法和应用 |
| CN119970741A (zh) | 2016-05-11 | 2025-05-13 | 贝达医药公司 | 作为用于治疗脑癌之治疗剂的2-苯胺基嘧啶衍生物 |
| MX383920B (es) | 2016-05-26 | 2025-03-14 | Recurium Ip Holdings Llc | Compuestos inhibidores de egfr. |
| EP3471730B1 (en) | 2016-06-17 | 2021-10-20 | Beta Pharma, Inc. | Pharmaceutical salts of n-(2-(2-(dimethylamino)ethoxy)-4-methoxy-5-((4-(1-methyl-1h-indol-3-yl)pyrimidin-2-yl)amino)phenyl)acrylamide and crystalline forms thereof |
| EP3492462B1 (en) | 2016-07-26 | 2023-08-30 | Shenzhen TargetRx, Inc. | Amino pyrimidine compound for inhibiting protein tyrosine kinase activity |
| CN107793413B (zh) * | 2016-09-05 | 2021-09-28 | 上海科州药物研发有限公司 | 嘧啶杂环化合物及其制备方法和应用 |
| CN106432231B (zh) * | 2016-09-09 | 2018-06-12 | 无锡佰翱得生物科学有限公司 | Azd9291的药用盐、及其晶型和制备方法 |
| CN106432249B (zh) * | 2016-09-30 | 2018-12-04 | 陕西科技大学 | 一类吡咯并[2，1-f][1，2，4]三嗪母核化合物的合成及其医药用途 |
| CN107973783B (zh) * | 2016-10-21 | 2024-09-06 | 正大天晴药业集团股份有限公司 | 作为erk抑制剂的苯胺嘧啶衍生物 |
| WO2018079310A1 (ja) | 2016-10-31 | 2018-05-03 | 大鵬薬品工業株式会社 | エクソン２０挿入変異型ｅｇｆｒ選択的阻害剤 |
| CN108057036B (zh) * | 2016-11-07 | 2023-06-13 | 正大天晴药业集团股份有限公司 | 一种egfr抑制剂的固体药物组合物 |
| CN108129342A (zh) * | 2016-11-30 | 2018-06-08 | 浙江九洲药物科技有限公司 | 一种奥希替尼中间体及其制备方法 |
| CN108503627A (zh) * | 2017-04-19 | 2018-09-07 | 郑州泰基鸿诺医药股份有限公司 | 用作egfr抑制剂的2,4-二取代苯-1,5-二胺衍生物及其应用 |
| CN106967050A (zh) * | 2017-05-11 | 2017-07-21 | 北京工业大学 | 一种azd9291的制备方法 |
| CN108864079B (zh) * | 2017-05-15 | 2021-04-09 | 深圳福沃药业有限公司 | 一种三嗪化合物及其药学上可接受的盐 |
| PE20191814A1 (es) | 2017-05-18 | 2019-12-27 | Idorsia Pharmaceuticals Ltd | Derivados de pirimidina como moduladores del receptor de pge2 |
| US11839613B2 (en) | 2017-05-18 | 2023-12-12 | Idorsia Pharmaceuticals Ltd | Pyrimidine derivatives as PGE2 receptor modulators |
| JP7028900B2 (ja) * | 2017-06-13 | 2022-03-02 | ベイジン アダマドル バイオテクノロジー リミテッド ライアビリティ カンパニー | アミノピリミジン化合物、その調製方法、およびその使用 |
| TW201904577A (zh) | 2017-06-16 | 2019-02-01 | 美商貝達醫藥公司 | N-(2-(2-二甲胺基)乙氧基)-4-甲氧基-5-((4-(1-甲基-1h-吲哚-3-基)嘧啶-2-基)胺基)苯基)丙烯醯胺及其鹽之醫藥調配物 |
| WO2019010619A1 (zh) * | 2017-07-10 | 2019-01-17 | 焦玉奇 | 2-(2,4,5-取代苯胺)嘧啶衍生物 |
| PL3677266T3 (pl) | 2017-09-01 | 2024-07-01 | Taiho Pharmaceutical Co., Ltd. | Selektywny inhibitor egfr z mutacją w eksonie 18 i/lub eksonie 21 |
| CN107556293B (zh) * | 2017-09-19 | 2019-12-03 | 福建省微生物研究所 | 一种奥西替尼的合成工艺 |
| UY37935A (es) * | 2017-10-18 | 2020-03-31 | Spectrum Pharmaceuticals Inc | Inhibidores de tirosina quinasas de la familia de los egfr mutantes |
| AU2019209470A1 (en) | 2018-01-16 | 2020-08-13 | Syros Pharmaceuticals, Inc. | Inhibitors of cyclin-dependent kinase 7 (CDK7) |
| US11918592B2 (en) | 2018-01-16 | 2024-03-05 | Syros Pharmaceuticals, Inc. | Inhibitors of cyclin dependent kinase 7 (CDK7) |
| KR102170422B1 (ko) * | 2018-01-25 | 2020-10-27 | 경동제약 주식회사 | 토파시티닙의 신규 염, 이의 제조방법 및 이를 포함하는 약학 조성물 |
| CN108283628B (zh) * | 2018-04-20 | 2021-01-01 | 南京康川济医药科技有限公司 | 一种抗癌药物微囊制剂及其制备方法 |
| JP2021523208A (ja) * | 2018-05-14 | 2021-09-02 | アリアド ファーマシューティカルズ， インコーポレイテッド | ピリミジン誘導体の医薬塩及び障害の処置方法 |
| CN110606842B (zh) * | 2018-06-15 | 2021-06-01 | 上海艾力斯医药科技股份有限公司 | 吡啶胺基嘧啶衍生物的制备方法及其中间体 |
| TWI831259B (zh) * | 2018-06-15 | 2024-02-01 | 漢達生技醫藥股份有限公司 | 包含達沙替尼十二烷基硫酸鹽組合物的膠囊 |
| CN110698461B (zh) * | 2018-07-09 | 2024-04-05 | 上海翰森生物医药科技有限公司 | 第三代egfr抑制剂的制备方法 |
| KR101954370B1 (ko) | 2018-07-25 | 2019-03-05 | 한미약품 주식회사 | 피리미딘 화합물 및 이를 포함하는 암의 예방 또는 치료용 약학 조성물 |
| CN110776495A (zh) * | 2018-07-30 | 2020-02-11 | 罗赟 | 激酶抑制剂的晶型及其制备方法和用途 |
| CN110790749B (zh) * | 2018-08-03 | 2023-07-14 | 北京普祺医药科技股份有限公司 | 一种含氮杂环化合物、药物组合物以及其用途 |
| CR20210287A (es) | 2018-11-01 | 2022-02-15 | Syros Pharmaceuticals Inc | Inhibidores de cinasa 7 dependiente de ciclina (cdk7) |
| JP7516029B2 (ja) * | 2018-11-16 | 2024-07-16 | アムジエン・インコーポレーテツド | Ｋｒａｓ ｇ１２ｃ阻害剤化合物の重要な中間体の改良合成法 |
| US11174263B2 (en) | 2018-12-31 | 2021-11-16 | Biomea Fusion, Inc. | Inhibitors of menin-MLL interaction |
| SG11202106304RA (en) * | 2018-12-31 | 2021-07-29 | Biomea Fusion Llc | Irreversible inhibitors of menin-mll interaction |
| BR112021016522A2 (pt) | 2019-02-22 | 2021-10-26 | Hanmi Pharm. Co., Ltd. | Composição farmacêutica para o tratamento da leucemia mieloide aguda |
| CN111606889B (zh) * | 2019-02-25 | 2023-03-07 | 上海翰森生物医药科技有限公司 | 4-(1-环丙基-1h-吲哚-3-基)-n-苯基嘧啶-2-胺衍生物的制备方法 |
| CN109761960B (zh) * | 2019-02-25 | 2021-08-31 | 江苏豪森药业集团有限公司 | 抗耐药抗肿瘤egfr抑制剂的制备方法 |
| US12157730B2 (en) | 2019-03-19 | 2024-12-03 | Voronoi Inc. | Heteroaryl derivative, method for producing same, and pharmaceutical composition comprising same as effective component |
| PT3943491T (pt) | 2019-03-19 | 2025-07-28 | Voronoi Inc | Derivado de heteroarilo, método para a produção do mesmo e composição farmacêutica que compreende o mesmo como componente eficaz |
| CN111747950B (zh) * | 2019-03-29 | 2024-01-23 | 深圳福沃药业有限公司 | 用于治疗癌症的嘧啶衍生物 |
| CN111777620A (zh) * | 2019-04-04 | 2020-10-16 | 山东轩竹医药科技有限公司 | 酪氨酸激酶抑制剂的新用途 |
| CN109942550A (zh) * | 2019-04-15 | 2019-06-28 | 广州医科大学附属第一医院（广州呼吸中心） | 11c标记的egfr正电子示踪剂及其制备方法和应用 |
| US20220340547A1 (en) * | 2019-05-22 | 2022-10-27 | Shanghi Hansoh Biosoh Biomedical Co., Ltd. | Indole derivative-containing inhibitor, preparation method therefor and application thereof |
| CA3143919A1 (en) * | 2019-06-20 | 2020-12-24 | Oncobix Co., Ltd. | Pyrimidine derivative inhibiting growth of cancer cell and medicinal use thereof |
| EA202290154A1 (ru) | 2019-06-27 | 2022-03-29 | Ханми Фарм. Ко., Лтд. | Фармацевтическая композиция для лечения острого миелоидного лейкоза, содержащая ингибитор flt3 и химиотерапевтические агенты |
| WO2021000957A1 (zh) * | 2019-07-04 | 2021-01-07 | 北京国鸿生物医药科技有限公司 | 一种杂环化合物、其药物组合物及用途 |
| CN110283162B (zh) * | 2019-07-09 | 2022-04-05 | 辽宁大学 | 一种表皮生长因子受体抑制剂及其应用 |
| CA3145686C (en) * | 2019-07-26 | 2023-03-21 | Charles Z. Ding | Pyrimidine compound acting on egfr and erbb2 |
| TW202128670A (zh) * | 2019-11-26 | 2021-08-01 | 大陸商上海翰森生物醫藥科技有限公司 | 含氮多環類衍生物抑制劑、其製備方法和應用 |
| WO2021127456A1 (en) | 2019-12-19 | 2021-06-24 | Rain Therapeutics Inc. | Methods of inhibiting epidermal growth factor receptor proteins |
| JP7626774B2 (ja) | 2020-02-03 | 2025-02-04 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | ＨＥＲ２阻害薬としての［１，３］ジアジノ［５，４－ｄ］ピリミジン |
| EP4100409B1 (en) | 2020-02-03 | 2024-08-28 | Boehringer Ingelheim International GmbH | [1,3]diazino[5,4-d]pyrimidines as her2 inhibitors |
| WO2021180238A1 (zh) * | 2020-03-13 | 2021-09-16 | 郑州同源康医药有限公司 | 一类用作激酶抑制剂的化合物及其应用 |
| CN111303125A (zh) * | 2020-04-10 | 2020-06-19 | 天津法莫西医药科技有限公司 | 一种甲氧基取代吲哚-嘧啶类化合物及其制备方法 |
| US11608343B2 (en) | 2020-04-24 | 2023-03-21 | Boehringer Ingelheim International Gmbh | Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors |
| WO2021243596A1 (en) * | 2020-06-03 | 2021-12-09 | InventisBio Co., Ltd. | Aminopyrimidine compounds, preparation methods and uses thereof |
| US20230234941A1 (en) * | 2020-06-23 | 2023-07-27 | Shenzhen Forward Pharmaceuticals Co., Limited. | Salts of Compound and Pharmaceutical Compositions Containing the Same |
| CN113861195B (zh) * | 2020-06-30 | 2022-11-18 | 上海和誉生物医药科技有限公司 | 一种多稠环egfr抑制剂及其制备方法和应用 |
| CN112159392B (zh) * | 2020-09-15 | 2021-11-23 | 南京雷正医药科技有限公司 | 取代嘧啶化合物及其药物组合物和该化合物的用途 |
| CN114907349A (zh) * | 2021-02-10 | 2022-08-16 | 江苏恒瑞医药股份有限公司 | 稠合的氮杂三环类衍生物、其制备方法及其在医药上的应用 |
| CN115197203B (zh) * | 2021-04-12 | 2024-06-25 | 上海医药工业研究院 | 苯胺嘧啶类化合物、其制备方法及应用 |
| TW202309022A (zh) | 2021-04-13 | 2023-03-01 | 美商努法倫特公司 | 用於治療具egfr突變之癌症之胺基取代雜環 |
| WO2023277172A1 (en) | 2021-06-30 | 2023-01-05 | Takeda Pharmaceutical Company Limited | Process for preparing pharmaceutical salts of pyrimidine derivatives |
| JP7734995B2 (ja) * | 2021-08-06 | 2025-09-08 | 上海和誉生物医薬科技有限公司 | ピリミジンまたはピリジン誘導体およびその製造方法ならびに薬学上の応用 |
| TW202320796A (zh) | 2021-08-11 | 2023-06-01 | 美商拜歐米富士恩股份有限公司 | 用於糖尿病的menin-mll相互作用之共價抑制劑 |
| US12018032B2 (en) | 2021-08-20 | 2024-06-25 | Biomea Fusion, Inc. | Crystalline forms of N-[4-[4-(4-morpholinyl)-7H-pyrrolo[2,3-d]pyrimidin-6-yl]phenyl]-4-[[3(r)-[(1-oxo-2-propen-1-yl)amino]-1-piperidinyl]methyl]-2-pyridinecarboxamide as an irreversible inhibitor of menin-MLL interaction |
| TW202317106A (zh) * | 2021-08-27 | 2023-05-01 | 南韓商柳韓洋行 | 作為egfr抑制劑之取代胺基吡啶化合物 |
| US20230113775A1 (en) * | 2021-09-10 | 2023-04-13 | Palvella Therapeutics, Inc. | Anhydrous compositions of egfr inhibitors and methods of use |
| CN114014847B (zh) * | 2021-12-08 | 2023-11-03 | 滨州医学院 | 一种含苯并噻吩嘧啶衍生物及其制备方法和在制备抗肿瘤药物中的应用 |
| CN114213339B (zh) * | 2021-12-20 | 2023-10-31 | 苏州康纯医药科技有限公司 | 一种表皮细胞生长因子受体突变抑制剂的制备方法 |
| WO2024155710A1 (en) | 2023-01-18 | 2024-07-25 | Biomea Fusion, Inc. | Crystalline forms of n-[4-[4-(4-morpholinyl)-7h-pyrrolo[2,3-d]pyrimidin-6- yl]phenyl]-4-[[3(r)-[(l-oxo-2-propen-l-yl)amino]-l-piperidinyl]methyl]-2-pyridinecarboxamide as a covalent inhibitor of menin-mll interaction |
| KR20240152239A (ko) * | 2023-04-11 | 2024-10-21 | 보로노이 주식회사 | 피라졸로피리딘 유도체 화합물 및 이의 용도 |
| WO2025229177A1 (en) | 2024-05-02 | 2025-11-06 | Idorsia Pharmaceuticals Ltd | Crystalline forms of an n-substituted indole derivative |
| WO2026053183A1 (en) * | 2024-09-09 | 2026-03-12 | Hetero Labs Limited | Benzothiazole and benzoxazole compounds as egfr inhibitors |
Family Cites Families (128)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3536809A (en) | 1969-02-17 | 1970-10-27 | Alza Corp | Medication method |
| US3598123A (en) | 1969-04-01 | 1971-08-10 | Alza Corp | Bandage for administering drugs |
| US3845770A (en) | 1972-06-05 | 1974-11-05 | Alza Corp | Osmatic dispensing device for releasing beneficial agent |
| US3916899A (en) | 1973-04-25 | 1975-11-04 | Alza Corp | Osmotic dispensing device with maximum and minimum sizes for the passageway |
| US4008719A (en) | 1976-02-02 | 1977-02-22 | Alza Corporation | Osmotic system having laminar arrangement for programming delivery of active agent |
| US4270537A (en) | 1979-11-19 | 1981-06-02 | Romaine Richard A | Automatic hypodermic syringe |
| HU196714B (en) | 1984-10-04 | 1989-01-30 | Monsanto Co | Process for producing non-aqueous composition comprising somatotropin |
| IE58110B1 (en) | 1984-10-30 | 1993-07-14 | Elan Corp Plc | Controlled release powder and process for its preparation |
| US4596556A (en) | 1985-03-25 | 1986-06-24 | Bioject, Inc. | Hypodermic injection apparatus |
| US5023252A (en) | 1985-12-04 | 1991-06-11 | Conrex Pharmaceutical Corporation | Transdermal and trans-membrane delivery of drugs |
| CN1029958C (zh) | 1986-03-31 | 1995-10-11 | 联合碳化农产化学品公司 | 丙二酸衍生物阻滞植物生长的用途 |
| JP2749578B2 (ja) | 1986-03-31 | 1998-05-13 | ローヌープーラン・ネーデルランド・ベー・ベー | 相乗的植物成長調節剤組成物 |
| EP0261226A1 (en) | 1986-03-31 | 1988-03-30 | Rhone Poulenc Nederland B.V. | Use of malonic acid derivative compounds for increasing crop yield |
| CA1283827C (en) | 1986-12-18 | 1991-05-07 | Giorgio Cirelli | Appliance for injection of liquid formulations |
| GB8704027D0 (en) | 1987-02-20 | 1987-03-25 | Owen Mumford Ltd | Syringe needle combination |
| US5001139A (en) | 1987-06-12 | 1991-03-19 | American Cyanamid Company | Enchancers for the transdermal flux of nivadipine |
| US4992445A (en) | 1987-06-12 | 1991-02-12 | American Cyanamid Co. | Transdermal delivery of pharmaceuticals |
| US4941880A (en) | 1987-06-19 | 1990-07-17 | Bioject, Inc. | Pre-filled ampule and non-invasive hypodermic injection device assembly |
| US4940460A (en) | 1987-06-19 | 1990-07-10 | Bioject, Inc. | Patient-fillable and non-invasive hypodermic injection device assembly |
| US4790824A (en) | 1987-06-19 | 1988-12-13 | Bioject, Inc. | Non-invasive hypodermic injection device |
| US5339163A (en) | 1988-03-16 | 1994-08-16 | Canon Kabushiki Kaisha | Automatic exposure control device using plural image plane detection areas |
| US5073543A (en) | 1988-07-21 | 1991-12-17 | G. D. Searle & Co. | Controlled release formulations of trophic factors in ganglioside-lipsome vehicle |
| FR2638359A1 (fr) | 1988-11-03 | 1990-05-04 | Tino Dalto | Guide de seringue avec reglage de la profondeur de penetration de l'aiguille dans la peau |
| GB8827305D0 (en) | 1988-11-23 | 1988-12-29 | British Bio Technology | Compounds |
| IT1229203B (it) | 1989-03-22 | 1991-07-25 | Bioresearch Spa | Impiego di acido 5 metiltetraidrofolico, di acido 5 formiltetraidrofolico e dei loro sali farmaceuticamente accettabili per la preparazione di composizioni farmaceutiche in forma a rilascio controllato attive nella terapia dei disturbi mentali organici e composizioni farmaceutiche relative. |
| PH30995A (en) | 1989-07-07 | 1997-12-23 | Novartis Inc | Sustained release formulations of water soluble peptides. |
| US5120548A (en) | 1989-11-07 | 1992-06-09 | Merck & Co., Inc. | Swelling modulated polymeric drug delivery device |
| US5064413A (en) | 1989-11-09 | 1991-11-12 | Bioject, Inc. | Needleless hypodermic injection device |
| US5312335A (en) | 1989-11-09 | 1994-05-17 | Bioject Inc. | Needleless hypodermic injection device |
| US5733566A (en) | 1990-05-15 | 1998-03-31 | Alkermes Controlled Therapeutics Inc. Ii | Controlled release of antiparasitic agents in animals |
| US5190521A (en) | 1990-08-22 | 1993-03-02 | Tecnol Medical Products, Inc. | Apparatus and method for raising a skin wheal and anesthetizing skin |
| US5527288A (en) | 1990-12-13 | 1996-06-18 | Elan Medical Technologies Limited | Intradermal drug delivery device and method for intradermal delivery of drugs |
| GB9118204D0 (en) | 1991-08-23 | 1991-10-09 | Weston Terence E | Needle-less injector |
| SE9102652D0 (sv) | 1991-09-13 | 1991-09-13 | Kabi Pharmacia Ab | Injection needle arrangement |
| US5580578A (en) | 1992-01-27 | 1996-12-03 | Euro-Celtique, S.A. | Controlled release formulations coated with aqueous dispersions of acrylic polymers |
| US5328483A (en) | 1992-02-27 | 1994-07-12 | Jacoby Richard M | Intradermal injection device with medication and needle guard |
| US5383851A (en) | 1992-07-24 | 1995-01-24 | Bioject Inc. | Needleless hypodermic injection device |
| US5569189A (en) | 1992-09-28 | 1996-10-29 | Equidyne Systems, Inc. | hypodermic jet injector |
| US5334144A (en) | 1992-10-30 | 1994-08-02 | Becton, Dickinson And Company | Single use disposable needleless injector |
| TW333456B (en) | 1992-12-07 | 1998-06-11 | Takeda Pharm Ind Co Ltd | A pharmaceutical composition of sustained-release preparation the invention relates to a pharmaceutical composition of sustained-release preparation which comprises a physiologically active peptide. |
| US5455258A (en) | 1993-01-06 | 1995-10-03 | Ciba-Geigy Corporation | Arylsulfonamido-substituted hydroxamic acids |
| US5591767A (en) | 1993-01-25 | 1997-01-07 | Pharmetrix Corporation | Liquid reservoir transdermal patch for the administration of ketorolac |
| US6087324A (en) | 1993-06-24 | 2000-07-11 | Takeda Chemical Industries, Ltd. | Sustained-release preparation |
| WO1995024176A1 (en) | 1994-03-07 | 1995-09-14 | Bioject, Inc. | Ampule filling device |
| US5466220A (en) | 1994-03-08 | 1995-11-14 | Bioject, Inc. | Drug vial mixing and transfer device |
| IT1270594B (it) | 1994-07-07 | 1997-05-07 | Recordati Chem Pharm | Composizione farmaceutica a rilascio controllato di moguisteina in sospensione liquida |
| US5599302A (en) | 1995-01-09 | 1997-02-04 | Medi-Ject Corporation | Medical injection system and method, gas spring thereof and launching device using gas spring |
| US5863949A (en) | 1995-03-08 | 1999-01-26 | Pfizer Inc | Arylsulfonylamino hydroxamic acid derivatives |
| ES2153031T4 (es) | 1995-04-20 | 2001-05-16 | Pfizer | Derivados del acido arilsulfonil hidroxamico como inhibidores de mmp y tnf. |
| US5730723A (en) | 1995-10-10 | 1998-03-24 | Visionary Medical Products Corporation, Inc. | Gas pressured needle-less injection device and method |
| AU6242096A (en) | 1995-06-27 | 1997-01-30 | Takeda Chemical Industries Ltd. | Method of producing sustained-release preparation |
| TW448055B (en) | 1995-09-04 | 2001-08-01 | Takeda Chemical Industries Ltd | Method of production of sustained-release preparation |
| JP2909418B2 (ja) | 1995-09-18 | 1999-06-23 | 株式会社資生堂 | 薬物の遅延放出型マイクロスフイア |
| ATE225343T1 (de) | 1995-12-20 | 2002-10-15 | Hoffmann La Roche | Matrix-metalloprotease inhibitoren |
| US5893397A (en) | 1996-01-12 | 1999-04-13 | Bioject Inc. | Medication vial/syringe liquid-transfer apparatus |
| US5980945A (en) | 1996-01-16 | 1999-11-09 | Societe De Conseils De Recherches Et D'applications Scientifique S.A. | Sustained release drug formulations |
| GB9607549D0 (en) | 1996-04-11 | 1996-06-12 | Weston Medical Ltd | Spring-powered dispensing device |
| US6264970B1 (en) | 1996-06-26 | 2001-07-24 | Takeda Chemical Industries, Ltd. | Sustained-release preparation |
| KR20000067904A (ko) | 1996-07-18 | 2000-11-25 | 디. 제이. 우드, 스피겔 알렌 제이 | 매트릭스 메탈로프로테아제의 포스피네이트계 억제제 |
| KR20000068248A (ko) | 1996-08-23 | 2000-11-25 | 디. 제이. 우드, 스피겔 알렌 제이 | 아릴설포닐아미노 하이드록삼산 유도체 |
| US6419961B1 (en) | 1996-08-29 | 2002-07-16 | Takeda Chemical Industries, Ltd. | Sustained release microcapsules of a bioactive substance and a biodegradable polymer |
| CA2217134A1 (en) | 1996-10-09 | 1998-04-09 | Sumitomo Pharmaceuticals Co., Ltd. | Sustained release formulation |
| PT839525E (pt) | 1996-10-31 | 2004-10-29 | Takeda Chemical Industries Ltd | Preparacao de libertacao prolongada |
| WO1998027980A2 (en) | 1996-12-20 | 1998-07-02 | Takeda Chemical Industries, Ltd. | Method of producing a sustained-release preparation |
| JP3338064B2 (ja) | 1997-01-06 | 2002-10-28 | ファイザー・インク | 環状スルホン誘導体 |
| US5891474A (en) | 1997-01-29 | 1999-04-06 | Poli Industria Chimica, S.P.A. | Time-specific controlled release dosage formulations and method of preparing same |
| NZ336840A (en) | 1997-02-03 | 2001-01-26 | Pfizer Prod Inc | Arylsulfonylamino hydroxamic acid derivatives useful in the treatment of tumor necrosis factor and matrix metalloproteinase mediated diseases |
| JP2000507975A (ja) | 1997-02-07 | 2000-06-27 | ファイザー・インク | Ｎ−ヒドロキシ−β−スルホニルプロピオンアミド誘導体類及びそれらのマトリックスメタロプロテイナーゼ阻害薬としての使用 |
| EP0960098A1 (en) | 1997-02-11 | 1999-12-01 | Pfizer Inc. | Arylsulfonyl hydroxamic acid derivatives |
| US5993412A (en) | 1997-05-19 | 1999-11-30 | Bioject, Inc. | Injection apparatus |
| GB9725782D0 (en) | 1997-12-05 | 1998-02-04 | Pfizer Ltd | Therapeutic agents |
| IT1298087B1 (it) | 1998-01-08 | 1999-12-20 | Fiderm S R L | Dispositivo per il controllo della profondita' di penetrazione di un ago, in particolare applicabile ad una siringa per iniezioni |
| GB9801690D0 (en) | 1998-01-27 | 1998-03-25 | Pfizer Ltd | Therapeutic agents |
| US6613358B2 (en) | 1998-03-18 | 2003-09-02 | Theodore W. Randolph | Sustained-release composition including amorphous polymer |
| PA8469501A1 (es) | 1998-04-10 | 2000-09-29 | Pfizer Prod Inc | Hidroxamidas del acido (4-arilsulfonilamino)-tetrahidropiran-4-carboxilico |
| PA8469401A1 (es) | 1998-04-10 | 2000-05-24 | Pfizer Prod Inc | Derivados biciclicos del acido hidroxamico |
| KR19990085365A (ko) | 1998-05-16 | 1999-12-06 | 허영섭 | 지속적으로 약물 조절방출이 가능한 생분해성 고분자 미립구 및그 제조방법 |
| US6248363B1 (en) | 1999-11-23 | 2001-06-19 | Lipocine, Inc. | Solid carriers for improved delivery of active ingredients in pharmaceutical compositions |
| WO2002096933A1 (en) | 2001-05-30 | 2002-12-05 | Novartis Ag | 2-{[n-(2-amino-3-(heteroaryl or aryl)propionyl)-aminoacyl]-amino}-alkylboronic acid derivatives |
| PT1478648E (pt) | 2002-02-01 | 2014-07-15 | Ariad Pharma Inc | Compostos contendo fósforo e suas utilizações |
| US7019017B2 (en) | 2002-05-14 | 2006-03-28 | Baylor College Of Medicine | Small molecule inhibitors of HER2 expression |
| WO2005113556A1 (en) | 2004-05-13 | 2005-12-01 | Icos Corporation | Quinazolinones as inhibitors of human phosphatidylinositol 3-kinase delta |
| EP1778648A2 (en) | 2004-08-19 | 2007-05-02 | ICOS Corporation | Compounds useful for inhibiting chk1 |
| KR20080057296A (ko) | 2005-10-21 | 2008-06-24 | 머크 앤드 캄파니 인코포레이티드 | 칼륨 채널 억제제 |
| PT1948180E (pt) | 2005-11-11 | 2013-05-10 | Boehringer Ingelheim Int | Tratamento de combinação de cancro compreendendo inibidores de egfr/her2 |
| TW200826843A (en) | 2006-09-13 | 2008-07-01 | Sumitomo Chemical Co | Thiadiazole compound and use thereof |
| AU2007332493A1 (en) | 2006-12-14 | 2008-06-19 | Daiichi Sankyo Company, Limited | Imidazothiazole derivatives |
| FR2911139A1 (fr) | 2007-01-05 | 2008-07-11 | Sanofi Aventis Sa | Nouveaux derives de phenyl-(4-phenyl-pyrimidin-2-yl)amines, leur preparation a titre de medicaments, compositions pharmaceutiques et notamment comme inhibiteurs de ikk |
| FR2911140B1 (fr) | 2007-01-05 | 2009-02-20 | Sanofi Aventis Sa | Nouveaux derives de 2-anilino 4-heteroaryle pyrimides, leur preparation a titre de medicaments, compositions pharmaceutiques et notamment comme inhibiteurs de ikk |
| FR2911138B1 (fr) | 2007-01-05 | 2009-02-20 | Sanofi Aventis Sa | Nouveaux derives de n, n'-2,4-dianilinopyrimidines, leur preparation a titre de medicaments, compositions pharmaceutiques et notamment comme inhibiteurs de ikk |
| PL2171090T3 (pl) * | 2007-06-08 | 2013-09-30 | Genentech Inc | Markery ekspresji genów odporności guza na leczenie hamujące HER2 |
| CA2692379A1 (en) | 2007-07-02 | 2009-01-08 | Boehringer Ingelheim International Gmbh | Antiproliferative compounds based on 5-membered heterocycles |
| FR2919869B1 (fr) | 2007-08-09 | 2009-09-25 | Sanofi Aventis Sa | Nouveaux derives de n, n'-2,4-dianilinopyrimidines, leur preparation a titre de medicaments, compositions pharmaceutiques et notamment comme inhibiteurs de ikk |
| US8193182B2 (en) | 2008-01-04 | 2012-06-05 | Intellikine, Inc. | Substituted isoquinolin-1(2H)-ones, and methods of use thereof |
| MX2010007419A (es) | 2008-01-04 | 2010-11-12 | Intellikine Inc | Ciertas entidades quimicas, composiciones y metodos. |
| EP2228350A4 (en) | 2008-01-10 | 2010-12-29 | Asahi Glass Co Ltd | GLASS, COATING MATERIAL FOR A LIGHT EMITTING DEVICE AND LIGHT EMITTING DEVICE |
| EP2252293B1 (en) | 2008-03-14 | 2018-06-27 | Intellikine, LLC | Kinase inhibitors and methods of use |
| NZ603525A (en) * | 2008-06-27 | 2015-02-27 | Celgene Avilomics Res Inc | Pyrimidine based compound and uses thereof |
| BRPI0915231A2 (pt) | 2008-07-08 | 2018-06-12 | Intellikine Inc | compostos inibidores de quinase e métodos de uso |
| CA2738429C (en) | 2008-09-26 | 2016-10-25 | Intellikine, Inc. | Heterocyclic kinase inhibitors |
| CN101723936B (zh) * | 2008-10-27 | 2014-01-15 | 上海睿星基因技术有限公司 | 激酶抑制剂及其在药学中的用途 |
| WO2010093808A1 (en) | 2009-02-11 | 2010-08-19 | Reaction Biology Corp. | Selective kinase inhibitors |
| UY32582A (es) | 2009-04-28 | 2010-11-30 | Amgen Inc | Inhibidores de fosfoinositida 3 cinasa y/u objetivo mamífero |
| US9908884B2 (en) * | 2009-05-05 | 2018-03-06 | Dana-Farber Cancer Institute, Inc. | EGFR inhibitors and methods of treating disorders |
| EP2430013B1 (en) | 2009-05-13 | 2014-10-15 | Amgen Inc. | Heteroaryl compounds as pikk inhibitors |
| WO2011082266A2 (en) | 2009-12-30 | 2011-07-07 | Arqule, Inc. | Substituted heterocyclic compounds |
| UY33539A (es) * | 2010-08-02 | 2012-02-29 | Astrazeneca Ab | Compuestos químicos alk |
| WO2012020215A1 (en) | 2010-08-09 | 2012-02-16 | Centro Nacional De Investigaciones Oncológicas (Cnio) | Amino- imidazolothiadiazoles for use as protein or lipid kinase inhibitors |
| PE20140146A1 (es) | 2010-11-19 | 2014-02-06 | Incyte Corp | Derivados de pirrolopiridina y pirrolopirimidina sustituidos con ciclobutilo como inhibidores de jak |
| US9034884B2 (en) | 2010-11-19 | 2015-05-19 | Incyte Corporation | Heterocyclic-substituted pyrrolopyridines and pyrrolopyrimidines as JAK inhibitors |
| JP2014513724A (ja) | 2011-05-16 | 2014-06-05 | オーエスアイ・ファーマシューティカルズ，エルエルシー | 融合二環キナーゼ阻害剤 |
| KR20140039279A (ko) | 2011-06-08 | 2014-04-01 | 더 보드 어브 트러스티스 어브 더 리랜드 스탠포드 주니어 유니버시티 | 스캐폴드-키나아제 상호작용 봉쇄제 및 암을 치료하는데 있어서의 그 사용법 |
| EP4119551A1 (en) * | 2011-07-27 | 2023-01-18 | Astrazeneca AB | 2-(2,4,5-substituted-anilino)pyrimidine compounds |
| EP2647634A1 (en) * | 2012-04-02 | 2013-10-09 | Noscira, S.A. | Indole-pyrimidine derivatives and their therapeutic uses |
| WO2013169401A1 (en) * | 2012-05-05 | 2013-11-14 | Ariad Pharmaceuticals, Inc. | Compounds for inhibiting cell proliferation in egfr-driven cancers |
| AR091023A1 (es) | 2012-05-11 | 2014-12-30 | Abbvie Inc | Inhibidores del nampt |
| CN104684906B (zh) | 2012-05-11 | 2017-06-09 | 艾伯维公司 | Nampt抑制剂 |
| EP2968285A4 (en) | 2013-03-13 | 2016-12-21 | Flatley Discovery Lab | COMPOUNDS AND METHODS FOR THE TREATMENT OF CYSTIC FIBROSIS |
| TWI663166B (zh) * | 2013-04-24 | 2019-06-21 | 健生藥品公司 | 新化合物 |
| WO2015039613A1 (zh) | 2013-09-18 | 2015-03-26 | 北京韩美药品有限公司 | 抑制btk和/或jak3激酶活性的化合物 |
| KR101879422B1 (ko) | 2013-09-18 | 2018-07-17 | 베이징 한미 파마슈티컬 컴퍼니 리미티드 | Btk 및/또는 jak3 키나제의 활성을 억제하는 화합물 |
| CN104860941B (zh) | 2014-02-25 | 2017-03-22 | 上海海雁医药科技有限公司 | 2,4‑二取代苯‑1,5‑二胺衍生物及其应用以及由其制备的药物组合物和药用组合物 |
| EP3119763A1 (en) | 2014-03-18 | 2017-01-25 | Iteos Therapeutics | Novel 3-indol substituted derivatives, pharmaceutical compositions and methods for use |
| JP6468611B2 (ja) * | 2014-05-13 | 2019-02-13 | アリアド ファーマシューティカルズ， インコーポレイテッド | キナーゼ阻害のためのヘテロアリール化合物 |
| EP3778584A1 (en) * | 2014-06-19 | 2021-02-17 | ARIAD Pharmaceuticals, Inc. | Production process of 2-chloro-4-heteroaryl-pyrimidine derivatives |
| GB201416754D0 (en) | 2014-09-23 | 2014-11-05 | Mission Therapeutics Ltd | Novel compounds |
| WO2016054987A1 (zh) | 2014-10-11 | 2016-04-14 | 上海翰森生物医药科技有限公司 | Egfr抑制剂及其制备和应用 |
| TWI696617B (zh) | 2015-04-28 | 2020-06-21 | 大陸商上海復尚慧創醫藥研究有限公司 | 特定蛋白質激酶抑制劑 |
-
2015
- 2015-05-13 EP EP20178478.2A patent/EP3778584A1/en not_active Withdrawn
- 2015-05-13 MX MX2018015532A patent/MX383379B/es unknown
- 2015-05-13 HU HUE15810340A patent/HUE042390T2/hu unknown
- 2015-05-13 AP AP2017009690A patent/AP2017009690A0/en unknown
- 2015-05-13 AU AU2015277786A patent/AU2015277786B2/en not_active Ceased
- 2015-05-13 TR TR2019/03322T patent/TR201903322T4/tr unknown
- 2015-05-13 ME MEP-2019-53A patent/ME03334B/me unknown
- 2015-05-13 RS RS20190295A patent/RS58541B1/sr unknown
- 2015-05-13 UA UAA201612223A patent/UA121657C2/uk unknown
- 2015-05-13 GE GEAP201514706A patent/GEP20207111B/en unknown
- 2015-05-13 TN TN2016000560A patent/TN2016000560A1/en unknown
- 2015-05-13 EP EP18182201.6A patent/EP3409669B1/en active Active
- 2015-05-13 SI SI201530623T patent/SI3157916T1/sl unknown
- 2015-05-13 KR KR1020167034934A patent/KR102412037B1/ko not_active Expired - Fee Related
- 2015-05-13 US US15/319,637 patent/US10227342B2/en active Active
- 2015-05-13 GE GEAP201514379A patent/GEP20197011B/en unknown
- 2015-05-13 SG SG11201610517PA patent/SG11201610517PA/en unknown
- 2015-05-13 CA CA2949793A patent/CA2949793C/en active Active
- 2015-05-13 DK DK15810340.8T patent/DK3157916T3/en active
- 2015-05-13 CR CR20170011A patent/CR20170011A/es unknown
- 2015-05-13 ES ES15810340T patent/ES2715500T3/es active Active
- 2015-05-13 PH PH1/2016/502453A patent/PH12016502453B1/en unknown
- 2015-05-13 HR HRP20190407TT patent/HRP20190407T1/hr unknown
- 2015-05-13 WO PCT/US2015/030576 patent/WO2015195228A1/en not_active Ceased
- 2015-05-13 PT PT15810340T patent/PT3157916T/pt unknown
- 2015-05-13 CN CN201580044040.9A patent/CN106559991B/zh active Active
- 2015-05-13 IL IL274159A patent/IL274159B2/en unknown
- 2015-05-13 LT LTEP15810340.8T patent/LT3157916T/lt unknown
- 2015-05-13 MX MX2016016766A patent/MX361802B/es active IP Right Grant
- 2015-05-13 EP EP15810340.8A patent/EP3157916B1/en active Active
- 2015-05-13 SM SM20190142T patent/SMT201900142T1/it unknown
- 2015-05-13 PL PL15810340T patent/PL3157916T3/pl unknown
- 2015-05-13 JP JP2016573910A patent/JP6230205B2/ja active Active
- 2015-05-13 MA MA40240A patent/MA40240B1/fr unknown
- 2015-05-13 NZ NZ726723A patent/NZ726723A/en not_active IP Right Cessation
- 2015-05-13 MY MYPI2016704581A patent/MY186839A/en unknown
- 2015-05-13 SG SG10201913753VA patent/SG10201913753VA/en unknown
- 2015-05-13 PE PE2016002728A patent/PE20170268A1/es unknown
- 2015-05-13 KR KR1020227020579A patent/KR102628356B1/ko active Active
- 2015-05-13 EA EA201692261A patent/EA034691B1/ru not_active IP Right Cessation
- 2015-05-13 BR BR112016029662-1A patent/BR112016029662B1/pt not_active IP Right Cessation
- 2015-05-13 GE GEAP201914379A patent/GEAP201914379A/en unknown
- 2015-05-13 CN CN201910795310.XA patent/CN110526912B/zh active Active
- 2015-05-13 MA MA054253A patent/MA54253A/fr unknown
-
2016
- 2016-11-09 IL IL248859A patent/IL248859B/en active IP Right Grant
- 2016-11-28 ZA ZA2016/08224A patent/ZA201608224B/en unknown
- 2016-12-15 CL CL2016003222A patent/CL2016003222A1/es unknown
- 2016-12-16 CU CUP2016000185A patent/CU20160185A7/es unknown
- 2016-12-18 SA SA516380531A patent/SA516380531B1/ar unknown
-
2017
- 2017-01-17 CO CONC2017/0000386A patent/CO2017000386A2/es unknown
- 2017-01-18 EC ECIEPI20173553A patent/ECSP17003553A/es unknown
- 2017-05-19 US US15/600,023 patent/US9796712B2/en active Active
- 2017-08-23 JP JP2017160217A patent/JP6546630B2/ja active Active
- 2017-12-05 CL CL2017003103A patent/CL2017003103A1/es unknown
-
2019
- 2019-01-25 US US16/257,577 patent/US20190218212A1/en not_active Abandoned
- 2019-03-12 CY CY20191100293T patent/CY1121359T1/el unknown
- 2019-06-21 JP JP2019115443A patent/JP2019194217A/ja not_active Withdrawn
- 2019-07-17 AU AU2019206024A patent/AU2019206024A1/en not_active Abandoned
-
2021
- 2021-08-12 JP JP2021131767A patent/JP7212733B2/ja active Active
- 2021-08-31 US US17/463,457 patent/US11958850B2/en active Active
-
2023
- 2023-01-13 JP JP2023003712A patent/JP2023052388A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2018012712A5 (https=) | ||
| JP2017521394A5 (https=) | ||
| HRP20200624T1 (hr) | Derivati 2-(2,4,5-supstituiranog-anilino)pirimidina kao modulatori egfr korisni za liječenje raka | |
| SI3074386T1 (en) | New aminopyrimidine derivatives | |
| JP2018515514A5 (https=) | ||
| JP2014139226A5 (https=) | ||
| JP5956999B2 (ja) | ヘテロアリール化合物およびその使用 | |
| ES2648876T3 (es) | Dihidropirido[3,4-b]pirazinonas sustituidas como inhibidores duales de proteínas BET y quinasas tipo polo | |
| SI3106463T1 (en) | Compounds of substituted pyrazolo (1,5-) pyrimidine as inhibitors of TRK kinase | |
| ES2587864T3 (es) | Derivados de pirimidina | |
| IL292229A (en) | Pharmacological combination of prmt5 inhibitors | |
| BR112021002722A2 (pt) | compostos de pirazolo[3,4-b]piridina como inibidores de tam e met quinases | |
| HRP20240293T1 (hr) | Derivati kinazolina kao protutumorska sredstva | |
| CA2545527A1 (en) | Pyrazole derivatives as inhibitors of receptor tyrosyne kinases | |
| JP2012501312A5 (https=) | ||
| JP5852678B2 (ja) | 抗腫瘍剤の効果増強剤 | |
| RU2019120986A (ru) | Фармацевтическая комбинация, содержащая ингибитор alk и ингибитор shp2 | |
| JP2020504742A5 (https=) | ||
| JP2010500414A5 (https=) | ||
| NZ629442A (en) | Heterocyclyl compounds as mek inhibitors | |
| JP2016525076A5 (https=) | ||
| JP2017125037A (ja) | イミダゾピロリジノン化合物 | |
| HRP20171689T1 (hr) | Inhibitori kinazolina aktivirajućih mutantnih oblika receptora epidermalnog faktora rasta | |
| HRP20171748T1 (hr) | 6-amino kinazolina ili 3-cijano derivati kinolina, postupci priprave i njihova farmaceutska uporaba | |
| EP4529956A3 (en) | Dosage form compositions comprising an inhibitor of bruton s tyrosine kinase |